Logo
 Home | Sitemap | Contact us | Search | Language
Left Right
Home >> Industrial and Microbial Biotechnology >> Microbes and Microbial Genomics for Industry >> Biomineralization Depletion of Metals

Biomineralization : deposition of metals
Several examples of microbially induced chemical deposition are known. For instance, it has been suggested in several separate studies that in Venezuela and Alaska, gold deposits have arisen through such a process. It is suggested that negatively charged polymer on the outside of the bacteria attracts the positively charged gold particles in the soil, so that they clump together as grains and eventually as gold nuggets. It has also been demonstrated that metals like gold continue to accumulate on the negatively charged polymers even after the bacteria have died, so that the process can continue indefinitely giving gold nuggets. During early 1990’s association of lace like gold-decorated microbial structures with gold particles was demonstrated form nine Alaskan sites.

. In this study, preliminary evidence was also available for the presence of specific bacteria-Podomicrobium like budding bacteria, which are also involved in iron and manganese oxide deposition processes. Chlorella vulgaris and Bacillus cereus have also been shown, in the laboratory, to have the ability of nucleating metallic gold form dilute, solutions having, gold as Au(III) or as gold chloride.

Bacterial mineralization results from interaction of extruded metabolic products (iron, gases, polypeptides, electrons) with extraneous metal ions in the surrounding environment. Some of the bacterial mineralization are list. It is argued that genes responsible for mineralization in a variety of microbes can be isolated, cloned and transferred into E.coli, which may then help in metal deposition more efficiently.

The expression profile with first generation. Ad vectors is not suitable for the long-term correction of chronic diseases but is adequate for direct cell killing, for most immunotherapy strategies and for some acute diseases. The first generation vectors have an insert –size limit of ~7.5kb. The promoter used most frequently with Ad (and indeed all other vectors) is derived from cytomegalovirus(CMV), which gives strong expression in many cell types. Ad gives particularly, efficient gene transfer to the liver, such that dissemination form the site of local injection(such as tumours) and consequent liver transfection is the most serious safety concern. The most serious limitation of Ad vectors stems from their tendency to elicit strong immune and (at high doses) inflammatory responses. Single, large doses of Ad provoke neutralizing antibody response directed to proteins of the viral particle, which prevent binding to target cells and abrogate gene transfer upon repeat dosing by systemic administration routes in animals.

Overall, Ad is the easiest viral vector from the manufacturing viewpoint, allowing the production of large quantities with titre and in relatively robust formulations. Nevertheless, Ad shares with other viral vectors the problem that first-generation vector preparations are contaminated with replication competent virus (RCV), which arises through recombination between viral sequences in the vector and in the chromosome of the producer cells. Many of the clinical studies giving encouraging signs of efficacy use Ad vectors.They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts

The most advanced of these delivers the wild-type gene for the tumour suppressor P53 for induction of tumour –cell killing. A series of phase II studies is underway, testing this recombinant virus alone and in combination with chemotherapies for the local management of various cancers. The steps involved gene therapy are illustrated in Figure 15.1.They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts They are large viruses and so have the potential for accepting large inserts

 

Left Right